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Abstract
Background: Most gene finders score candidate gene models with state-based methods, typically
HMMs, by combining local properties (coding potential, splice donor and acceptor patterns, etc).
Competing models with similar state-based scores may be distinguishable with additional
information. In particular, functional and comparative genomics datasets may help to select among
competing models of comparable probability by exploiting features likely to be associated with the
correct gene models, such as conserved exon/intron structure or protein sequence features.
Results: We have investigated the utility of a simple post-processing step for selecting among a set
of alternative gene models, using global scoring rules to rerank competing models for more
accurate prediction. For each gene locus, we first generate the K best candidate gene models using
the gene finder Evigan, and then rerank these models using comparisons with putative orthologous
genes from closely-related species. Candidate gene models with lower scores in the original gene
finder may be selected if they exhibit strong similarity to probable orthologs in coding sequence,
splice site location, or signal peptide occurrence. Experiments on Drosophila melanogaster
demonstrate that reranking based on cross-species comparison outperforms the best gene models
identified by Evigan alone, and also outperforms the comparative gene finders GeneWise and
Augustus+.
Conclusion: Reranking gene models with cross-species comparison improves gene prediction
accuracy. This straightforward method can be readily adapted to incorporate additional lines of
evidence, as it requires only a ranked source of candidate gene models.
Background
Cross-species comparisons have been shown to be effec-
tive in locating genes and predicting gene structures. De
novo gene finders such as SGP2 [1], TWINSCAN [2,3],
NSCAN [4], SLAM [5], SAGA [6], DOGFISH [7], EXONI-
PHY [8], SHADOWER [9], CONTRAST [10] have
improved upon ab initio gene finders through comparison
with genomic sequences of reference species, capturing
phylogenetic footprints, as coding sequences tend to be
relatively highly conserved. Reference-based gene finders
such as DPS [11], Rosetta [12], Procrustes [13], GenomeS-
can [14], Projector [15], GeneWise [16], GeneMapper [17]
and ExonHunter [18] have sought to predict genes in tar-
get species through alignment with genes or proteins from
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reference species, modeling substitution patterns, gaps,
exon/intron length distribution, signals, and other poten-
tially conserved features. Augustus+ [19,20] extends
Augustus [21] by incorporating alignments with genes
and proteins of reference species into its ab initio gene
model. FgenesH++ [22] also extends an existing ab initio
prediction model with comparative evidence. Broadly
speaking, all of these gene finders employ the strategy of
adding comparative side-information to an existing ab ini-
tio model; genome annotation pipelines such as EnsEMBL
[23] and UCSC Known Genes [24] add comparative com-
ponents to ab initio models and expressed-sequence data
sources. JIGSAW [25,26] employs a somewhat different
strategy where ab initio and orthologous proteins are
treated as sources of evidence and integrated. All of these
gene finders effectively incorporate cross-species informa-
tion, achieving improvement in prediction accuracy over
single-species gene finders, although doing so often
requires significant effort in model and algorithm design
and implementation to cast comparative information into
a form compatible with the existing gene models.
We have developed a simple, yet effective, reranking
approach for incorporating cross-species information as a
post-processing step after initial gene prediction, obviat-
ing the need to build a new gene finder or laboriously
modifying an existing one to incorporate comparative
information. Reranking the K best hypotheses has been an
effective technique in natural language processing systems
[27-29]. For example, in speech recognition, it is a widely
adopted practice to generate the K  best recognition
hypotheses with a fast one-pass recognizer, and then
rerank them based on probabilities given by a more pow-
erful language model [30]. The gene finder Evigan [31]
integrates diverse sources of evidence, yielding a ranked
list of the top K candidate gene models, which may then
be reranked by comparing them with reference genes from
closely related species. Gene models with good (but not
necessarily best) probabilities defined by Evigan that also
exhibit strong similarity to reference genes may thus be
selected as most likely.
Results and discussion
To assess the feasibility and accuracy of reranking candi-
date gene models based on cross-species comparison, we
conducted an experiment seeking to identify gene models
in the genome of Drosophila melanogaster (stripped of all
annotation), using D. pseudoobscura as reference species.
D. melanogaster was selected because the extensive effort
that has been devoted to gene annotation in this species
provides a "gold standard" for assessing performance.
All data used in this experiment were downloaded from
FlyBase [32], including:
• Whole genome sequence for D. melanogaster (Release
5.1), used as the target genome for gene model predic-
tions.
￿ Ab initio gene model predictions from five gene finders
(Augustus [21], Genscan [33], Genie [34], GeneID [35]
and CONTRAST [10]), used as the input data for Evigan
gene model predictions [31].
￿ Annotated gene models of D. pseudoobscura (Release
2.0), used as reference for reranking candidate gene mod-
els in D. melanogaster.
￿ Annotated gene models of D. melanogaster, used as train-
ing set for estimating reranker parameters, and also as a
standard for evaluating prediction accuracy.
Evigan is a recently developed gene finder that integrates
diverse sources of evidence, including predictions from
multiple other gene finders. Using a dynamic Bayesian
network to create consensus predictions based on the pat-
terns of agreement and disagreement between the evi-
dence sources, Evigan produces more accurate calls than
any of the individual gene finders used as sources [31]. As
output Evigan provides a list of the K gene models with
the highest probabilities according to its evidence integra-
tion network.
Among the five source gene finders used as input for Evi-
gan, four (Augustus [21], Genscan [33], Genie [34] and
GeneID [35]) predict genes by examining the D. mela-
nogaster genomic sequence and modeling the nucleotide
composition surrounding start, stop, splice donor and
splice acceptor sites, codon usage and coding potential,
exon length distribution, and other sequence features. The
CONTRAST [10] gene finder predicts D. melanogaster
genes based on conservation with a reference species
genome, motivated by the assumption that coding
sequence is more likely to be conserved than non-coding
sequence. Although CONTRAST uses genomic nucleotide
sequence information from another species, none of the
source gene finders uses gene models or proteins to
improve gene model predictions.
Using the source gene finders' prediction sets, Evigan
identified 13,669 gene loci in the D. melanogaster genome
(see Methods). For each locus, Evigan was then used to
generate the K best candidate models (K ≤ 100), along
with the probability for each model [31]. Figure 1 shows
the number of candidate models identified per locus, and
the number of exons per gene. Fewer than 20 candidate
gene models were identified for 83% of the loci, although
some loci contain as many as 100 competing models. In
general, the number of plausible candidate models at a
locus is a function of the number of exons for this gene:BMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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for loci exhibiting an average of < 5 exons per gene, Evigan
identified a median number of 5 candidate models per
locus; a median of 33 candidate models were identified
for loci having an average of ≥ 5 exons per gene. The
number of candidate models per locus identified by Evi-
gan is based on the agreement among available evidence
sources (gene finders). Disagreements about exon call
multiply out for multi-exon genes, explaining the abun-
dance of candidate models for those genes.
To identify genes where cross-species comparison might
permit reranking of alternative gene models, D. mela-
nogaster loci predicted by Evigan were filtered to identify
those where: (i) Evigan suggested multiple candidate gene
models, and (ii) putative orthologs (see "Methods") were
identified in D. pseudoobscura. As indicated in Table 1, Evi-
gan identified 13,669 genes in the entire D. melanogaster
genome (some of the 14,550 genes curated in D. mala-
nogaster release v5.1 were not recognized by any of the
source gene finders, or only by a small subset, and were
therefore not identified as probable genes by Evigan).
Multiple candidate models were identified for 11,701
genes (86%), and 9125 genes (67%) were paired with D.
pseudoobscura genes as putative orthologs based on recip-
rocal best BLAST hits [36]; 7975 loci exhibited both mul-
tiple candidate models and putative orthologs. A small
sample (2.5%, 198 loci) of these genes were randomly
selected as a training set for estimating reranking parame-
ters, and the remainder (7777 loci) were used to test the
reranking algorithm. Note that the five source gene pre-
Number of candidate gene models per gene locus and number of exons per gene on Drosophila melanogaster Figure 1
Number of candidate gene models per gene locus and number of exons per gene on Drosophila melanogaster. 
Blue bars provide a histogram showing the number of candidate gene models per locus, as identified by Evigan-5g. The red scat-
ter plot shows the number of candidate gene models per locus versus the number of exons per gene (average number of 
exons per candidate where multiple candiates are predicted). Note that only a few candidate models are suggested for most 
genes; those with many candidate models predicted typically contain many exons.BMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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dictors were trained on their specific training sets, but it is
not very likely that they significantly overlap with the 198
loci randomly selected for estimating reranking parame-
ters; otherwise the reranking parameters estimated from
the training set would be biased and result in poor per-
formance.
The performance of Evigan-5g (which combines the five
ab initio source gene finders) and of ReRanker-5g (which
uses cross-species comparison to rerank the K best candi-
date gene models produced by Evigan-5g), were com-
pared against curated annotation of the D. melanogaster
genome (release 5.1). Performance metrics include sensi-
tivity and specificity on the gene, transcript and exon level
(see "Methods" for details), and the evaluation software
Eval [37] was used. As indicated in the top section of Table
2, ReRanker-5g always performs better than Evigan-5g, in
terms of both sensitivity and specificity, at the exon, tran-
script and gene levels for the genome, improving on the
advantage that Evigan typically shows over any of the
sources of evidence it integrates [31]. ReRanker-5g
selected the highest probability Evigan-5g model for 6031
loci (by construction for these loci Evigan-5g and
ReRanker-5g have the same prediction and thus the same
performance); 4333 of these (71.9%), agree with the D.
melanogaster genome annotation. Of the remaining 1746
loci where ReRanker-5g selected a lower probability Evi-
gan-5g model, the highest probability Evigan-5g model
was correct in only 252 cases (14.4%) whereas gene mod-
els selected by ReRanker-5g were correct for 500 cases
(28.6%), indicating much better performance of
ReRanker-5g than Evigan-5g. Results on these 1746 loci
are shown in Table 3. The performance of Evigan-5g is rel-
atively poor on these loci where genes contain relatively
more exons (6.6 exons per gene on average for Table 3 ver-
sus 4.6 exons per gene for Table 2) reflecting the difficul-
ties that genes of more exons pose to ab initio gene finders.
Reranking candidate Evigan models based on sequence
homology with D. pseudoobscura, however, significantly
increases performance for these genes. When offered a
selection of alternative gene models, cross-species com-
parison frequently allows ReRanker to select the correct
models.
When ReRanker selects an alternative model, does it
always choose the next most probable candidate from the
list of possibilities defined by Evigan? Figure 2 presents
the frequency and performance of ReRanker selections, as
a function of Evigan rank. ReRanker selected the second to
the fifth most probable Evigan model in 820 genes, the
sixth to the tenth most probable model in 228 genes; and
even lower probability models for 698 genes. Comparison
with the annotated D. melanogaster genome indicates that
even when relatively low ranking models were selected by
the reranking algorithm, these are more likely to be cor-
rect than the top probability Evigan model: the red lines
(ReRanker-5g) are higher than blue lines (Evigan-5g) in
Figure 2 for all exon, transcript and gene levels.
Incorporating Genie's prediction into ReRanker-5g
(through Evigan-5g) could have introduced a circularity,
because ReRanker's performance was evaluated on D. mel-
anogaster  annotations, which were developed with the
help of Genie. However, this does not appear to be the
case, since both ReRanker-5g and Evigan-5g significantly
outperform Genie for sensitivity and specificity on the
gene, transcript and exon level, as shown in Table 2. In
fact, ReRanker-5g and Evigan-5g significantly outperform
all of the five ab initio predictors used as evidence sources
for Evigan-5g (Table 2).
Another factor that migh raise concerns of circularity in
our evaluations is ReRanker's use of D. pseudoobscura as a
reference for gene prediction on D. melanogaster, since the
Table 1: Identification of D. melanogaster genes suitable for model reranking
D. melanogaster gene loci identified by Evigan-5g 13,669
Genes with multiple Evigan-5g candidate models 11,701
Genes with putative orthologs in D. pseudoobscura 9,125
Intersection (genes with multiple candidate models and putative orthologs) 7,975
Training set (2.5% of intersection, randomly selected) 1,98
Test set (used for Table 2) 7,777
Genes where ReRanker-5g selected the highest probability Evigan-5g model 6,031
Genes where ReRanker-5g selected a lower probability Evigan-5g model (used for Table 3) 1,746BMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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former was annotated based on the latter. To address this,
performance of ReRanker-5g and Evigan-5g were evalu-
ated on 1191 D. melanogaster loci whose putative
orthologs on D. pseudoobscura have EST support. Over
38,000 EST sequences for D. pseudoobscura were obtained
from dbEST [38] and aligned to D. pseudoobscura anno-
tated transcripts that were identified as the putative
orthologs of the entire test set (7777 transcripts), using
BLAST (E-value cutoff of 1e-5). The transcripts where the
aligned length covers more than half of the transcript
length were retained as a subset having independent
experimental support, resulting in 1191 transcripts. On
the D. melanogaster loci which are these transcripts' puta-
tive orthologs, performance of ReRanker-5g and Evigan-
5g were evaluated and presented in Table 4. ReRanker-5g
outperforms Evigan-5g for sensitivity and specificity at the
gene, transcript and exon level. The evaluation on the sub-
set with independent experimental evidence suggests that
ReRanker's improved performance is not likely to be
attributed to the two species' related annotation process.
A widely used alternative approach for using cross-species
information in gene prediction involves aligning refer-
ence gene models (or proteins) to the target genome, and
using these alignments to either build new gene finders, or
modify existing ab initio ones by explicitly modeling align-
ments. GeneWise [16] aligns protein sequences to target
genome sequences and uses the alignments to hypothe-
size introns, amino acid mutation patterns, sequencing
errors, exon length statistics, and other gene prediction
signals.
Augustus+ [20] extends the ab initio gene finder Augustus
[21] by considering transcript or protein alignments as
extrinsic hints, up- or down-weighting ab initio gene
parses based on consistency with the alignments. The bot-
tom half of Tables 2 and Table 3 compares the perform-
Table 2: Gene-finding performance for various algorithms.
Gene Transcript Exon
ALL initial internal terminal single
sn% sp% sn% sp% sn% sp% sn% sp% sn% sp% sn% sp% sn% sp%
Augustus 47.0 50.9 37.6 50.9 70.8 78.8 53.5 66.4 77.6 81.8 70.9 83.2 61.9 72.
CONTRAST 48.8 51.9 39.2 51.9 69.7 80.8 57.4 70.6 74.2 84.6 69.7 80.8 68.9 78.0
Geneid 35.9 41.4 29.3 41.4 65.7 71.4 47.0 60.9 75.6 73.9 59.2 72.8 54.6 73.7
Genie 40.7 50.0 31.9 50.0 58.2 77.9 44.1 63.7 63.1 82.7 58.8 80.2 58.7 68.8
Genscan 31.4 35.7 24.9 35.7 61.3 61.6 42.4 54.6 70.8 61.6 54.1 65.9 58.7 76.9
Evigan-5g 54.6 58.9 43.8 58.9 73.7 84.4 61.0 74.6 78.7 87.5 72.9 84.6 70.7 85.6
ReRanker-5g 57.6 62.1 46.1 62.1 74.2 85.4 61.8 75.9 79.0 88.5 73.9 85.9 71.6 86.3
GeneWise 29.4 31.0 25.0 31.0 58.3 73.9 41.8 56.7 69.5 90.9 48.5 59.4 32.3 30.6
Augustus+ 53.3 57.0 43.5 57.0 73.0 81.1 58.3 72.2 79.2 84.0 71.6 83.3 65.2 73.0
Evigan-6g 56.3 60.7 45.1 60.7 74.7 85.2 61.4 75.4 80.2 88.3 73.5 85.7 70.5 84.7
Performance on the entire D. melanogaster test set of 7777 loci (see Table 1). Augustus, CONTRAST, Geneid, Genie and Genscan are ab initio 
predictors used as evidence sources for Evigan-5g. ReRanker-5g selects among K-best gene models produced by Evigan-5g with cross-species 
information. GeneWise, Augustus+ and Evigan-6g are other comparative gene predictors or approaches. Bold indicates where ReRanker-5g 
outperforms Evigan-5g; italics indicates where other comparative approaches outperform ReRanker-5g (see text).BMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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ance of ReRanker-5g with GeneWise and Augustus+ on
the complete D. melanogaster test set, and the subset of
genes where Evigan-5g and ReRanker-5g chose different
models. GeneWise was employed to align D. pseudoob-
scura proteins to their putative orthologous loci in D. mel-
anogaster  (using default parameters). GeneWise
predictions of CDS, donor, acceptor, start and stop infor-
mation were then provided as extrinsic hints for Augus-
tus+ (using ab initio parameters trained for Drosophila
melanogaster and default parameters for extrinsic protein
hints). Evigan was also run to integrate GeneWise models
with the five ab initio source gene finders described above,
yielding Evigan-6g.
Augustus+, GeneWise and some other comparative pre-
dictors do not need ortholog detection; rather they align
reference genes or proteins to a target genome and then
refine signal predictions for significant hits. This strategy
tends to identify relatively more target genes and thus
enjoy higher sensitivity. For ReRanker, where putative
ortholog detection is needed, if ortholog detection for a
gene fails, ReRanker misses the opportunity to locate the
gene and will thus show lower sensitivity. However,
ReRanker's main goal is to improve specificity by improv-
ing the prediction of exact structures for genes whose
existence and rough locations have been reasonably vali-
dated.
On the whole D. melanogaster test set (Table 2), ReRanker-
5g outperformed GeneWise and Augustus+ in terms of
both sensitivity and specificity, at the exon-, transcript-,
and gene-level (although GeneWise exhibited slightly
greater specificity, and Augustus+ slightly greater sensitiv-
ity, in recognizing internal exons). ReRanker-5g also out-
performed Evigan-6g as assessed by all criteria except for
overall and internal exon sensitivity. In cases where
ReRanker-5g and Evigan-5g make different choices (Table
3), ReRanker-5g outperforms GeneWise and Evigan-6g,
but performs worse than Augustus+ in most categories.
The better performance of Augustus+ (on this subset of
genes, but not the genome as a whole; Table 2) may arise
from increased sensitivity by using homology informa-
tion in its ab initio model used to search for gene seg-
ments. The relatively poor performance of ReRanker-5g
would then follow from a relative lack of candidates in the
source evidence: ReRanker-5g is constrained to select from
among the potential models suggested by Evigan-5g,
which performs relatively poorly on this subset. These
observations highlight the extent to which Evigan and
ReRanker are limited by available sources of evidence, in
particular the source gene finders, but it is important to
note that the inclusion of additional gene predictions in
the mix is likely to improve the performance of Evigan
and thus ReRanker.
Conclusion
We have demonstrated that ReRanker leads to improve-
ment in prediction accuracy through a simple strategy of
incorporating additional evidence. There are many direc-
tions along which the work can be extended or improved.
The first step of the reranking strategy is to identify single-
gene loci on a target species. If this step finds incorrect
loci, such as loci that contain more than one gene, partial
genes or pseudo genes, it could mislead ReRanker, which
Table 3: Gene-finding performance for genes where ReRanker-5g differs from Evigan-5g.
Gene Transcript Exon
ALL initial internal terminal single
sn% sp% sn% sp% sn% sp% sn% sp% sn% sp% sn% sp% sn% sp%
Evigan-5g 11.9 14.4 8.7 14.4 64.5 76.8 42.3 58.4 73.3 81.5 55.8 73.1 3.6 17.4
ReRanker-5g 23.6 28.6 16.6 28.6 66.11 79.6 45.1 63.0 73.9 83.5 59.3 77.9 13.5 64.3
GeneWise 18.8 21.5 14.4 21.5 56.4 75.7 32.5 49.2 66.9 88.5 41.2 55.9 9.9 14.7
Augustus+ 30.2 33.5 21.9 33.5 67.4 76.2 46.7 62.2 75.3 80.1 59.8 74.3 16.3 23.0
Evigan-6g 19.0 23.1 13.7 23.1 67.5 79.1 43.8 60.7 76.8 83.3 58.7 77.3 2.8 17.4
Performance on the 1746 loci where ReRanker-5g selected a lower probability Evigan-5g model based on cross-species comparison. Note that 
ReRanker-5g improves on Evigan-5g acrosss the board; italics indicates where other comparative approaches outperform ReRanker-5g (see text).BMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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assumes that a locus contains a single gene. In the
ortholog identification step, most of those wrong loci will
be removed because they tend to not be associated with
orthologs from a reference species. But it would be very
useful to devise an additional step before reranking, to
identify problematic loci and even recover correct locus
Table 4: Gene-finding performance for D. melanogaster genes with D. pseudoobscura EST evidence.
Gene Transcript Exon
ALL initial internal terminal single
sn% sp% sn% sp% sn% sp% sn% sp% sn% sp% sn% sp% sn% sp%
Evigan-5g 71.0 74.6 59.2 74.64 78.1 88.9 72.0 86.3 81.8 90.0 77.9 90.0 81.4 89.2
ReRanker-5g 75.6 79.4 63.2 79.4 79.4 91.2 74.0 88.8 82.5 92.7 79.8 91.8 81.8 89.6
Performance on the 1191 D. melanogaster loci whose putative orthologs on D. pseudoobscura are supported by EST sequences (see text for details). 
Note that ReRanker-5g improves on Evigan-5g across the board (improvement indicated by bold).
Performance by rank on Drosophila melanogaster Figure 2
Performance by rank on Drosophila melanogaster. The table on the bottom right shows the number of loci where 
ReRanker-5g selects Evigan-5g candidate gene models of certain rank. For example, there are 6031 loci where ReRanker 
selects the most probable candidate models as defined by Evigan; there are 820 loci where ReRanker-5g selects the second to 
the fifth most probable candidate models as defined by Evigan, and so on. The other panels show the F-score (harmonic mean 
of sensitivity and specificity) of Evigan-5g and ReRanker-5g at the exon, transcript and gene levels for various rank ranges. 
ReRanker is successful at improving the identification of correct gene models even when selected candidates are far from the 
top of the list provided by Evigan.
Rank of candidate models selected by ReRanker Rank of candidate models selected by ReRanker
Rank of candidate models selected by ReRanker
Transcript-level  F-score
Gene-level  F-score
34 91~100 82 30~40
28 81~90 131 21~30
32 71~80 210 11~20
47 61~70 228 6~10
55 51~60 820 2~5
79 41~50 6031 1
#loci rank #loci rank
Exon-level  F-score
ReRanker-5g
Evigan-5g
ReRanker-5g
ReRanker-5g
Evigan-5g
Evigan-5gBMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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information. The reranking strategy is sufficiently general,
in the sense that it is neither specific to Evigan candidate
gene models, nor limited to incorporating information
from cross-species comparisons. The same conceptual
strategy could readily be applied to candidate gene mod-
els produced by other annotation pipelines as well as
accommodate diverse sources of evidence in place of or in
addition to comparative genomics data. For example, one
can easily envision further improving gene models selec-
tion by reranking based on protein sequence motifs or sig-
nals, transcript or protein expression data, etc. In addition
it is natural to relate Evigan's K-best gene models to alter-
native transcripts, which might allow us to extend
ReRanker for predicting multiple transcripts on a target
species, if the putative ortholog on a reference species
exhibits alternative transcripts.
Methods
This section details how ReRanker prioritizes candidate
gene models on a target species by comparison with
orthologs from a reference species. Subsections address
the generation of candidate gene models, ortholog identi-
fication between the two species, the construction of sim-
ilarity features between gene models, the format of
scoring function of candidate gene models and learning of
the reranker's scoring parameters.
Generating candidate gene models
Gene loci on the target species were first defined and can-
didate gene models for each locus are generated by Evi-
gan. The term gene locus refers to a genomic region
containing only a single gene. Gene loci on the target spe-
cies were first identified by an initial prediction gene set
produced by Evigan integrating multiple lines of evidence
(Augustus, Genscan, Genie, Geneid, CONTRAST were
used in the experiment). The genomic region defined by
each gene in the initial prediction set is extended in both
directions on the genomic sequence until the neighboring
predicted genes are reached. Each such extended region is
a gene locus. This procedure often produces thousands or
tens of thousands of gene loci on the target species,
depending on the size of the genome and the Evigan ini-
tial prediction set.
For each proposed gene locus, Evigan was used to generate
the K best candidate gene models for the gene with the
posterior probability for each, by integrating the evidence
overlapping with the region. K is a parameter passed to
the K best decoder in Evigan as the maximum number of
alternative paths to be generated. If the aggregated evi-
dence at this locus supports less than K candidate gene
models, all possible models will be generated. The K-best
decoder [39] in Evigan uses a variation of the Viterbi
decoding algorithm [40,41] to search for high probability
paths, with O(K N log  N) computational complexity
where N is the size of the standard Viterbi trellis, which is
quite efficient. In the original Viterbi decoding implemen-
tation of Evigan, an optimal path may contain multiple
genes, whereas in the implementation of the K-best
decoder only single-gene paths are returned. Note that the
best candidate in the K-best list for a locus may or may not
be exactly the same as the initially predicted gene used to
identify the locus. In practice, however, discrepancy is
rarely observed.
Ortholog identification
Ortholog pairs between the target species and a reference
species are identified by BLASTP [42] reciprocal best hits
between the best candidate models (translated into pro-
tein products) on the target species and the proteins on
the reference species. Specifically, if a gene's best candi-
date model on the target species and a protein from the
reference species are reciprocal best hits by running
BLASTP(default parameters, e-value cutoff set as 1e-5),
they are considered as an ortholog pair. This is a rather
simplified approach for identifying orthologs but in prac-
tice it produces reasonably good results. More compre-
hensive approaches would be searching all candidate
models of a gene against the reference proteins or examin-
ing multiple species and phylogentic relationships
between the species [36,43].
Reranking features
A variety of features were extracted from candidate gene
models, including the posterier probabilities defined by
Evigan and various similarity features determined by com-
parison with orthologous proteins/gene models. Note
that these features could readily be expanded to include
additional informative similarity features. In the current
implementation, six features on a candidate gene model
were extracted, as described below. Let t and r denote a
candidate gene model (or its translated protein) on the
target species and a protein/gene on the reference species,
respectively.
Posterior probability
Let p(t) denote t's Evigan posterior probability given the
evidence. The probability feature f1(t) is the logarithm of
p(t):
f1(t) = log p(t)
Length similarity
Let l(t) and l(r) denote the coding sequence length of t and
r. The length similarity feature f2(t) is given by
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The absolute difference in the coding length of the two
genes |l(t) - l(r)| is normalized by the coding length l(r) of
the reference gene. (Normalizing by the coding length of
the target gene model is not a good idea, because it may
bias towards target candidate gene models that are very
long or short.) The +1 term in the numerator and denom-
inator smoothes the counts.
Splice count similarity
As with coding length, we also compare the number of
splice sites in source and target. Let s(t) and s(t) denote the
number of splice sites of t and r. The splice site feature f3(t)
is given by
Again, the +1 term in the numerator and denominator
smoothes the counts, and also prevents division by zero.
Sequence similarity
The sequence similarity feature between t and r is com-
puted from the alignment score given by DiAlign [44], a
multiple sequence alignment program. When two
sequences are aligned, DiAlign first searches for multiple
gapless local alignments, referred to as segments, and then
constructs a global alignment between the two sequences
by searching for the best set of consistent segments. In
addition to producing gapless local alignments, DiAlign
also provides for each segment an alignment score, which
is basically the negative logarithm of the probability that
two random sequences can be aligned as well as these two
sequences. Suppose the coding sequences of t and r are
aligned by DiAlign (translated alignment) and let A(t, r)
denote the sum of the alignment scores for the segments
constituting the global alignment and A(t, r) is roughly
linear to the length of t and r. The sequence similarity fea-
ture f4(t) is given by normalizing the alignment score by
the length of r, or
Shared splice sites
The segments produced by DiAlign can be used to extract
another useful similarity feature: shared splice sites. Figure
3 shows the alignment betweeen the coding sequences of
t and r output by DiAlign, where blue boxes represent gap-
less local alignments and wavy lines represent unaligned
regions. Splice sites of t and r are mapped to the segments,
as shown by the arrows in the figure. If a splice site of t and
a splice site of r are mapped to the same relative position
within a segment, as exemplified by the first and third
pairs of splice sites in the figure, they are identified as a
shared splice site. Let C(t, r) denote the number of shared
splice sites identified by the above approach. The shared
splice feature f5(t) is given by
Signal peptides
A signal peptide feature, f6(t), represents the co-occurence
of predicted signal peptide on t and r. The presence or
absence of signal peptides on t and r is predicted by sig-
nalP-3.0 [45]. Let S(t) and S(r) denote the presence or
absence of signal peptides on t and r. Then the feature f6(t)
is given by
If the reference gene contains a signal peptide, target can-
didate gene models with signal peptides are preferred; If
the reference gene does not contain signal peptide, no
preference is imposed on target candidate gene models.
The one-sided nature of the feature is motivated by the rel-
atively low abundance of signal peptides and the observa-
tion that signal peptide detection algorithms tend to focus
on sensitivity rather than specificity. If the reference gene
does not have a signal peptide while a target candidate
model does, the candidate will not be penalized.
Scoring function
The features just described are used to compute a score
S(t) for each candidate gene model t. The features of t are
arranged into a feature vector f(t), and the score is defined
by the inner product S(t) = f(t)·w, where w is a weight vec-
tor that will be learned from training data. Given K candi-
date gene models t1, ..., tK, the index of the highest scoring
model is given by the decision rule
Weight estimation
The parameter weight vector w in the scoring function is
estimated from a training set D  to optimize reranking
accuracy using the MIRA online large-margin learning
algorithm [46].
The training set D = {e1, ..., eN} is a set of training exam-
ples, where each example e ∈ D contains the set of candi-
date models for a training gene. More specifically, each e
∈ D has the form e = {(tk, qk)|k = 1, ..., K} where tk is a can-
didate model and qk is the quality of tk relative to the ref-
erence annotation. In our experiments, qk is the exon-level
F-score (harmonic mean of sensitivity and specificity) for
tk relative to the reference annotation genes at tk's locus.
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The MIRA learning algorithm [46] learns w by looping
over the training examples and updating w at each exam-
ple so that lowest-error candidate model is selected for the
example by the decision rule given above. The weight vec-
tor w is initially the zero vector. The pseudocode "Outline
of MIRA update" shows a single cycle of updating the
weight vector. At each round, the algorithm fetches an
example  e  from the training set, reranks its candidate
models and selects the best predicted candidate tk* using
the current weight vector. The true best candidate is
denote by  , given by the maximum quality assessment.
The algorithm updates the weight vector by solving an
optimization problem. The goals of the optimization
problem are two-fold: keep the new weight vector as close
to the current weight vector as possible; and score the true
best candidate higher than the predicted candidate by
their quality difference  . C is a weight factor bal-
ancing the two goals, which is set to 5 in the experiments.
The algorithm will loop over the examples in the training
set until the weight vector does not change significantly.
Outline of MIRA update
Given an example e = {(tk, qk)|k = 1, ..., K} and a current
weight vector wn, the updated weight vector wn+1 ← MIRA-
update(e, wn) is computed as follows:
- Use the current weight vector wn to rank the candidate
models and select the index for best predicted candidate
by k* = arg maxk = 1...K f(tk)·wn
- Let   be the index of the true best candidate   = arg
maxk = 1...K qk
- Find the solution w, ξ for the following optimization
problem:
- Set wn+1 = w.
It is common practice to consider the average of the
updated weight vector at each round as the final output
weight vector, because the average weight vector often
gives better performance than individual weight vectors
[46]. The pseudo-code titled "MIRA algorithm wrapper"
shows an algorithm wrapper that calls the MIRA update as
a subroutine at each round and outputs a final weight vec-
tor.
MIRA algorithm wrapper
Given a training set D, the algorithm wrapper computes a
weight vector w ← MIRA-wrapper(D) as follows:
- Initialize the weight vector w0 ← 0
- Perform the following N times:
- Get an example e from the training set D
- Update the weight vector wn+1 ← MIRA-update(e, wn)
- Output the average weight vector 
Evaluation
For each locus on the target species, Evigan's prediction is
always the top gene model from the original candidate list
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Infering shared splice sites from alignement Figure 3
Infering shared splice sites from alignement. Blue boxes represent segments (local alignments) produced by DiAlign [44] 
between coding sequences of two gene models and the wavy lines represent unaligned regions. Arrows represent mapped 
splice sites. The first and third pairs of overlapping splice sites are identified as shared splice sites.BMC Bioinformatics 2008, 9:433 http://www.biomedcentral.com/1471-2105/9/433
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generated by Evigan; ReRanker's prediction is the candi-
date model with the highest reranking score as described
above. Performance of prediction sets is assessed by sensi-
tivity and specificity on exon, transcript and gene level
using the Eval program [37] (only coding parts were eval-
uated). Sensitivity is defined as the fraction of annotated
exons (or genes) predicted correctly. Specificity is the frac-
tion of the predicted exons (or genes) that correspond pre-
cisely to any exon (or gene) in the curated annotation set.
F-score is the harmonic mean of sensitivity and specificity.
An exon is considered correct if its boundaries and reading
frame are both correct. A gene is counted correct if all of
its exons are precisely predicted. For genes with multiple
transcripts, sensitivity and specificity were determined at
the exon, transcript and gene levels. A transcript is consid-
ered correct if all its exons are accurately predicted. A gene
is counted correct if one of its transcripts is predicted cor-
rectly.
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